Table 6.
Effect of pterocarpan-high soy leaf extract supplementation on changes of plasma lipids concentrations in subjects with metabolic syndrome.
| Placebo | PT | Time × Group, p Value † | |||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Triglyceride (mg/dL) | 187.19 ± 17.62 | 178.91 ± 14.99 | 176.41 ± 11.54 | 161.79 ± 13.13 | 0.243 |
| Free fatty acid (mmol/L) | 2.25 ± 0.08 | 1.98 ± 0.07 * | 2.42 ± 0.15 | 1.60 ± 0.13 *** | 0.000 |
| Total Cholesterol (mg/dL) | 165.54 ± 6.75 | 165.14 ± 6.43 | 173.00 ± 5.04 | 155.19 ± 7.80 * | 0.077 |
| HDL-cholesterol (mg/dL) | 38.54 ± 2.87 | 26.34 ± 2.19 | 32.90 ± 2.27 | 36.38 ± 2.42 | 0.375 |
| non HDL-cholesterol (mg/dL) | 128.11 ± 7.70 | 132.68 ± 7.44 | 130.28 ± 10.74 | 108.76 ± 11.36 * | 0.014 |
| LDL-cholesterol (mg/dL) | 91.77 ± 6.92 | 92.89 ± 6.68 | 107.24 ± 5.10 | 92.64 ± 7.80 | 0.801 |
| AI | 3.77 ± 0.38 | 3.81 ± 0.30 | 4.59 ± 0.36 | 3.81 ± 0.39 | 0.692 |
Values are the mean ± SE. Placebo, starch; PT, pterocarpan-high soy leaf extract (2 g/day); HDL, high density lipoprotein; LDL, low density lipoprotein; AI, atherogenic index. * p < 0.05, *** p < 0.000 paired t-test between before and after trial in each group. † p < 0.05 general linear model for repeated measures ANOVA.